4 679

Cited 8 times in

Yonsei Criteria: A New Protocol for Active Surveillance in the Era of Robotic and Local Ablative Surgeries

Authors
 Sey Kiat Lim  ;  Kwang Hyun Kim  ;  Tae-Young Shin  ;  Byung Ha Chung  ;  Sung Joon Hong  ;  Young Deuk Choi  ;  Koon Ho Rha 
Citation
 CLINICAL GENITOURINARY CANCER, Vol.11(4) : 501-507, 2013 
Journal Title
CLINICAL GENITOURINARY CANCER
ISSN
 1558-7673 
Issue Date
2013
MeSH
Cohort Studies ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Grading* ; Neoplasm Recurrence, Local ; Prostate/pathology ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatectomy/methods ; Prostatic Neoplasms/diagnosis* ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Robotics
Keywords
Gleason 6 ; Prostate cancer ; Prostatectomy ; Robot ; low risk
Abstract
BACKGROUND:
The objective of this study was to develop a new AS protocol and compare it with the existing selected published AS protocols by examining the pathological characteristics of post-RARP specimens in patients eligible for AS.
MATERIALS AND METHODS:
From a database of 1046 patients, 344 post-RARP patients with biopsy Gleason scores ≤ 6 prostate cancer (PCa) without neoadjuvant therapy were included. Six AS protocols were identified and evaluated for pathological and oncological end points. Four new AS criteria were proposed and evaluated. The probabilities of each end point were estimated using logistic regression modeling. Areas under the receiver operating curve were calculated for each protocol and end point.
RESULTS:
Across all the selected protocols, biochemical recurrence occurred in 0 to 1.9% of patients; extracapsular extension (ECE) in 0 to 5.9%; lymph node involvement (LNI) in 0 to 1.3%; and upgrading to Gleason score ≥ 7 in 12.9% to 36.4%. We found that our new AS criteria: cT1-cT2 PCa; biopsy Gleason score ≤ 6; prostate-specific antigen ≤ 10 ng/mL; ≤ 1 positive biopsy core; and ≤ 50% core involvement compared favorably with other protocols. Area under the receiver operating curve analyses showed good predictive power of our AS criteria for the pathological and oncological end points of our study.
CONCLUSION:
Existing AS protocols do not satisfactorily predict insignificant PCas in our cohort, hence necessitating the need for new AS criteria in the era of robotic and local ablative surgeries. No patients in our cohort had biochemical recurrence, LNI, or ECE of their PCas when our protocol was applied.
Full Text
http://www.sciencedirect.com/science/article/pii/S1558767313000852
DOI
10.1016/j.clgc.2013.04.024
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Kwang Hyun(김광현)
Rha, Koon Ho(나군호) ORCID logo https://orcid.org/0000-0001-8588-7584
Shin, Tae Young(신태영)
Lim, Sey Kiat(임세이캣)
Chung, Byung Ha(정병하) ORCID logo https://orcid.org/0000-0001-9817-3660
Choi, Young Deuk(최영득) ORCID logo https://orcid.org/0000-0002-8545-5797
Hong, Sung Joon(홍성준) ORCID logo https://orcid.org/0000-0001-9869-065X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/88530
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links